XLO: Xilio Therapeutics Inc. filed SEC Form 8-K: Leadership Update
Stocks in this Quantisnow insightHealth Care
Keep researching XLO
- What is Form 8-K?The SEC "current report" a public company files to disclose material events, generally within four business days of the event.
- Form 8-K explainedWhat a Form 8-K is, when it is due, and what each key item number means, from 1.01 material agreements and 2.02 earnings to 4.02 restatements and 5.02 executive changes.
- XLO insider tradesEvery buy and sale reported by Xilio Therapeutics Inc. officers, directors and large holders.
- XLO financial statementsRevenue, profit, cash flow and balance sheet from Xilio Therapeutics Inc.'s SEC filings.
Quantisnow market dataNASDAQ
XLO
Xilio Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Get push alerts for XLO
Full XLO profile on Quantisnow Follow XLO and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time